ChemoCentryx Reports Fourth Quarter 2015 Financial Results and Provides Corporate Update
Mar 14, 2016 20:05 pm UTC| Business
-- Successful Phase II ‘CLEAR’ Clinical Trial Demonstrated Rapid Onset of Benefit While Eliminating Need for Chronic High-Dose Steroids in ANCA-Associated Vasculitis (AAV) With Complement Inhibitor CCX168 -- --...
State National Companies to Present at NYSSA 20th Annual Insurance Industry Conference
Mar 14, 2016 20:05 pm UTC| Business
BEDFORD, Texas, March 14, 2016 -- State National Companies, Inc. (NASDAQ:SNC) today announced that its management will be participating in the New York Society of Security Analysts (NYSSA) 20th Annual Insurance...
Ekso Bionics Reports Fourth Quarter and Year End 2015 Results
Mar 14, 2016 20:05 pm UTC| Business
RICHMOND, Calif., March 14, 2016 -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today reported financial results for the three and twelve months ended December 31, 2015. Recent Highlights...
Mar 14, 2016 20:05 pm UTC| Business
RANCHO CUCAMONGA, Calif., March 14, 2016 -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the fourth quarter and fiscal year ended December 31, 2015. Fourth...
Connecture, Inc. Announces $52 Million Investment Led By Francisco Partners
Mar 14, 2016 20:05 pm UTC| Business
Additional capital helps position Company for strategic growthChrysalis Ventures to participate in investment BROOKFIELD, Wis., March 14, 2016 -- Connecture, Inc. (NASDAQ:CNXR), a provider of web-based information...
Harvard Bioscience Announces Delay in Filing Form 10-K
Mar 14, 2016 20:05 pm UTC| Business
Reports Delay is Result of Forensic Investigation Following Minor Employee TheftWill schedule conference call to discuss fourth quarter and full year 2015 results upon completion of the investigation HOLLISTON, Mass.,...
Mar 14, 2016 20:05 pm UTC| Business
NEWARK, Calif., March 14, 2016 -- Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in aesthetic and therapeutic indications, today announced a key addition to...